One year after officials in Greece began investigating Novartis on bribery allegations in a probe that quickly assumed soap-opera proportions, the country’s leaders are ratcheting up the pressure—implicating 10 former ministers and ordering one of the Swiss pharma giant’s local managers not to leave the country pending prosecution.Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.